http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105985376-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-60 |
| filingDate | 2015-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105985376-B |
| titleOfInvention | [2-(1H)-quinolinone-3-yl]aminomethylphosphonate and its preparation method and application |
| abstract | The present invention relates to [2-(1H)-quinolinone-3-yl] aminomethyl phosphonate or its salt shown in chemical structural formula I: R is selected from: C 1 ~C 2 alkyl, C 3 ~C 4 straight chain alkyl or branched chain alkyl; X 1 , X 2 are selected from: hydrogen, deuterium, C 1 ~C 2 alkyl; X 3 , X 7 is selected from: hydrogen, deuterium, C 1 ~C 2 alkyl, fluorine, chlorine, bromine, iodine or nitro; X 4 , X 6 are selected from: hydrogen, deuterium, C 1 ~C 2 alkyl; X 5 selected from: hydrogen, deuterium, C 1 -C 2 alkyl or nitro; n=0 or 1. Application of [2-(1H)-quinolinone-3-yl]aminomethylphosphonate or its salt in the preparation of neuraminidase inhibitors. |
| priorityDate | 2015-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 246.